IL4 and COVID-19: Most notably, PBMCs from COVID-19 patients were enriched in JAK-STAT and IL-4 signaling, which has been known to drive inflammation following infection (Lu et al., 2011; de la Rica et al., 2020; Satarker et al., 2021).